Knight Cancer signal achievements of 2022
People at the Knight Cancer Institute accomplished a lot in 2022. Through innovative, collaborative research and education, the institute delivers cancer prevention, detection, and care — one...
Tag: driver mutation
Cancer genome study reveals big window for early detection
Tell-tale DNA errors arise years before tumors become dangerous. For cancers that can’t currently be detected early, a new discovery suggests there may be a large window of time in which to look...
Overcoming the impasse in acute myeloid leukemia research
Nine drug companies and six universities have now joined an unusual collaboration to break the logjam in research on acute myeloid leukemia (AML), a blood cancer lacking effective treatments....
Genomic drivers of a poorly understood kidney cancer
Researchers have identified many of the altered genes and cell signaling pathways that drive papillary renal cell carcinoma, a poorly understood form of cancer that accounts for about 15 percent of...